Search research articles
Contact Us
Filters
Showing results (21-30 of 168) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells
Wanping Xu, Len Neckers
ACS Chemical Biology
|
December 14, 2006
Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive
Gabriela Chiosis, Len Neckers
Cancer Cell
|
June 15, 2016
Gr(i)p the ER to Stress Out Melanoma
Wanping Xu, Len Neckers
Seminars in Oncology
|
December 18, 2017
Uncoupling tumor-stroma interactions in breast cancer patients
Carole Sourbier, Len Neckers
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2004
Epithelial-directed drug delivery: influence of formulation and delivery devices
James L Mulshine, Len Neckers
Advances in Cancer Research
|
February 27, 2016
Hsp90 in Cancer: Transcriptional Roles in the Nucleus
Stuart K Calderwood, Len Neckers
Current Opinion in Oncology
|
November 19, 2003
Heat shock protein 90
Len Neckers, S Percy Ivy
Cancer Cell
|
March 12, 2015
The GLU that holds cancer together: targeting GLUtamine transporters in breast cancer
Michael A Moses, Len Neckers
Expert Opinion on Drug Discovery
|
March 15, 2013
Post-translational modification of heat-shock protein 90: impact on chaperone function
Bradley T Scroggins, Len Neckers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2013
Stressing the development of small molecules targeting HSP90
Len Neckers, Jane B Trepel
Page
of 17
Search research articles
Search
Showing results (21-30 of 168) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells
Wanping Xu, Len Neckers
ACS Chemical Biology
|
December 14, 2006
Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive
Gabriela Chiosis, Len Neckers
Cancer Cell
|
June 15, 2016
Gr(i)p the ER to Stress Out Melanoma
Wanping Xu, Len Neckers
Seminars in Oncology
|
December 18, 2017
Uncoupling tumor-stroma interactions in breast cancer patients
Carole Sourbier, Len Neckers
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2004
Epithelial-directed drug delivery: influence of formulation and delivery devices
James L Mulshine, Len Neckers
Advances in Cancer Research
|
February 27, 2016
Hsp90 in Cancer: Transcriptional Roles in the Nucleus
Stuart K Calderwood, Len Neckers
Current Opinion in Oncology
|
November 19, 2003
Heat shock protein 90
Len Neckers, S Percy Ivy
Cancer Cell
|
March 12, 2015
The GLU that holds cancer together: targeting GLUtamine transporters in breast cancer
Michael A Moses, Len Neckers
Expert Opinion on Drug Discovery
|
March 15, 2013
Post-translational modification of heat-shock protein 90: impact on chaperone function
Bradley T Scroggins, Len Neckers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2013
Stressing the development of small molecules targeting HSP90
Len Neckers, Jane B Trepel
Page
of 17